Cargando…
Do patients with advanced breast cancer benefit from chemotherapy?
This study aimed to assess the proportion of patients with advanced breast cancer who report benefit from first-line palliative chemotherapy using a simple global measure of wellbeing and to identify factors predicting benefit. A consecutive series of women with advanced breast cancer undergoing fir...
Autores principales: | Ramirez, A. J., Towlson, K. E., Leaning, M. S., Richards, M. A., Rubens, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063215/ https://www.ncbi.nlm.nih.gov/pubmed/9836482 |
Ejemplares similares
-
Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.
por: Twelves, C. J., et al.
Publicado: (1994) -
Chemotherapy of advanced breast cancer: outcome and prognostic factors.
por: Gregory, W. M., et al.
Publicado: (1993) -
Do all patients with breast cancer benefit from neoadjuvant chemotherapy?
por: Lee, Kyoung Eun
Publicado: (2020) -
Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
por: Grunfeld, E A, et al.
Publicado: (2001) -
Advanced breast cancer: use of resources and cost implications.
por: Richards, M. A., et al.
Publicado: (1993)